Hermon, M <br/><br/>
Intravenous prostacyclin mitigates inhaled nitric oxide rebound effect: A case control study.  [electronic resource] 

 -  Artificial organs  Nov 1999 
 - 975-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0160-564X 
<br/><br/><label>Standard No.: </label>10.1046/j.1525-1594.1999.06448.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Analysis of Variance<br/>Antihypertensive Agents--administration & dosage<br/>Case-Control Studies<br/>Child<br/>Child, Preschool<br/>Endothelium, Vascular--drug effects<br/>Epoprostenol--administration & dosage<br/>Extracorporeal Membrane Oxygenation<br/>Heart Defects, Congenital--surgery<br/>Humans<br/>Hypertension, Pulmonary--drug therapy<br/>Infant<br/>Infant, Newborn<br/>Injections, Intravenous<br/>Lung--blood supply<br/>Nitric Oxide--administration & dosage<br/>Oxygen--blood<br/>Oxygen Consumption--drug effects<br/>Retrospective Studies<br/>Vascular Resistance--drug effects<br/>Vasodilator Agents--administration & dosage